AOD-9604
HGH fragment. Lipolysis without the GH side.
- Sizes available
- 2mg · 5mg · 10mg
- Lab certificate (COA)
- Supplier-published sample
· Research-grade only · Not for human consumption · 21+ ·
GH fragment. Fat loss only, without IGF-1 or glucose effects.
Mechanism · Modified HGH 176-191 fragment. Lipolytic-only. AOD-9604 = Metabolic Pharmaceuticals.
Mechanism, dose, ramp, risk.
- Mechanism
- Modified fragment of HGH (176-191). Promotes fat oxidation without affecting IGF-1.Source · PEPVERA editorial
- Target dose
- 300 mcg / day, subq.Source · PEPVERA editorial
- Ramp
- Begin full dose. 8-week cycle.Source · PEPVERA editorial
- Risks
- Mild injection-site reaction.Source · PEPVERA editorial
Compared to its siblings.
AOD-9604
GH fragment. Fat loss only, without IGF-1 or glucose effects.
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 5 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Ameano PeptidesUS | $38$19.00/mg · 2mg | Sample COA published | 2 days | |
| Ameano PeptidesUS | $58$11.60/mg · 5mg | Sample COA published | 2 days | |
| Ascension PeptidesUS | $64.99$13.00/mg · 5mg | Sample COA published | 3 days | |
| Royal PeptidesUS | $65$13.00/mg · 5mg | Sample COA published | 3 days | |
| Verified PeptidesUS | $67.99$6.80/mg · 10mg | Sample COA published | 3 days | Out of stock |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
0.25 mg / wk
Baseline ramp
Week 3–4
0.5 mg / wk
Hold, observe
Week 5–8
1.0–2.0 mg / wk
Ascend
Week 9–12
300 mcg / day, subq.
Terminus
Draw 20 units.
0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.
cut · IX · Ameano Peptides
AOD-9604 · 2mg